Target intelligence / Profile preview

Retinoid-related orphan receptor alpha (RORA)

Target
RORA
Molecular classification
Nuclear receptor, Transcription factor, Steroid hormone receptor superfamily, NR1 subfamily
01

Overview

Retinoid-related orphan receptor alpha (RORα), also known as NR1F1, is a ligand-dependent nuclear receptor and transcription factor that plays a fundamental role in the mammalian circadian clock by positively regulating the expression of BMAL1. It is widely expressed across tissues including the liver, skeletal muscle, brain, and adipose tissue, where it coordinates lipid and glucose metabolism, limits inflammation, and promotes cellular differentiation. RORα is essential for the maturation of Purkinje cells in the cerebellum and the development of Type 2 innate lymphoid cells (ILC2s). Dysregulation of RORα is strongly linked to metabolic syndrome, atherosclerosis, and autoimmune disorders, as well as neuropsychiatric conditions like autism and depression. In oncology, RORα often acts as a tumor suppressor, and its activation with small-molecule agonists is being explored as a therapeutic strategy for metabolic dysfunction-associated steatohepatitis (MASH) and cardiovascular diseases.

Other names
NR1F1Nuclear receptor RORARAR-related orphan receptor alphaRetinoic acid receptor-related orphan receptor alphaRZRAROR1ROR2ROR3
02

Mechanism of action

Binds as a monomer to ROR response elements (ROREs) in the promoter regions of target genes to recruit coactivators (such as p300 and PGC-1α) and stimulate transcription; agonists enhance this recruitment, while inverse agonists promote the recruitment of corepressors (such as NCoR) to inhibit gene expression.

03

Biological functions

Circadian rhythm regulationLipid metabolismGlucose homeostasisImmune responseCellular differentiationApoptosisCerebellar developmentBone formationAngiogenesisMitophagy
04

Disease associations

Metabolic dysfunction-associated steatohepatitis (MASH)Metabolic syndromeObesityAtherosclerosisCardiovascular diseaseCancer (Breast, Gastric, Colorectal)Autoimmune disease (Multiple sclerosis)AsthmaAutism spectrum disorderMajor depressive disorderOsteoporosis
05

Safety considerations

Neurotoxicity (potential for cerebellar ataxia)Off-target metabolic dysregulationImmune system imbalanceDisruption of circadian rhythmsPleiotropic effects across multiple organ systems
06

Interacting drugs

TB-840

9 more in the full profile.

07

Biomarkers

RORA mRNA expression levelsRORA genetic variants (SNPs)BMAL1 expression levelsIL-17 cytokine levelsPlasma oxysterol levels

Beyond the preview

Go deeper on Retinoid-related orphan receptor alpha (RORA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Retinoid-related orphan receptor alpha (RORA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call